Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,600 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Brain and Behavior, 2025Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study
Wang H., Cheng Z., Xu Z. et al.
Olink Target 96
Cell, 2025Human proteome distribution atlas for tissue-specific plasma proteome dynamics
Malmström E., Malmström L., Hauri S. et al.
Olink Explore 3072/384
GeroScience, 2025Associations between plasma proteomic signatures and secondary sleep in older adults
Madhawa K., Svensson T., Nt H. et al.
Scientific Reports, 2025Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis
Miclea A., Zurawski J., Healy B. et al.
Thrombosis Journal, 2025Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations
Daghlas I., Wang M., Gill D.
npj Precision Oncology, 2025Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment
Cui S., Zheng H., Xu Y. et al.
Arthritis & Rheumatology, 2025Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development
Rachid Zaim S., Savage A., Gillespie M. et al.
Cell Genomics, 2025Integration of biobank-scale genetics and plasma proteomics reveals evidence for causal processes in asthma risk and heterogeneity
Donoghue L., Benner C., Chang D. et al.
Cell Reports Medicine, 2025Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients
Hu M., Oliveira A., Fang Z. et al.
Mediators of Inflammation, 2025Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis
Wu Z., Yang J., Zhu Y. et al.
Neurological Research, 2025Mediators of the causal associations between protein ratios and ischemic stroke: a two-step Mendelian randomization study
Tan H., Chen H., Yan H. et al.
International Journal of Cancer, 2025Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer
Cooley V., Fortner R., Mukama T. et al.
Nature Medicine, 2025Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial
Temba G., Pecht T., Kullaya V. et al.
Journal of Proteome Research, 2025Identification of Salivary Biomarkers in Colorectal Cancer by Integrating Olink Proteomics and Metabolomics
Su H., Gu X., Zhang W. et al.
Urolithiasis, 2025Effect of the plasma metabolites, biomarkers, and inflammatory proteins on urolithiasis: insights from Mendelian randomization and mediation analysis
Huang H., Wen Z., Li H. et al.
Cell Reports, 2025Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic
Molinos-Albert L., Rubio R., Martín-Pérez C. et al.
Proceedings of the National Academy of Sciences, 2025Nuclear Galectin-1 promotes KRAS -dependent activation of pancreatic cancer stellate cells
Vinaixa J., Martínez-Bosch N., Gibert J. et al.
Cell Reports Medicine, 2025TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
Plummer R., Sodergren M., Hodgson R. et al.
Annals of Laboratory Medicine, 2025Pancreatic Cancer Detection and Differentiation from Chronic Pancreatitis: Potential Biomarkers Identified through a High-Throughput Multiplex Proteomic Assay and Machine Learning-Based Analysis
Kim Y., Kim S., Lee S.
Discover Oncology, 2025Appraising the causal role of cathepsins in genitourinary carcinoma: a two-sample mendelian randomization and prospective study based on 36,225 individuals
Zhu Q., Liu D., Liu H. et al.
3743 publications
Items per page
1121-1140 of 3743 publications